BioNTech SE (BNTX)
Nasdaq: BNTX · Biological Products, (No Diagnostic Substances) · Mainz, DE · filing with the SEC since 2019
Who owns BioNTech SE
As filed with the SECHolders of 5% or more
3
Athos Kg holds 40.2% of Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares), as its SCHEDULE 13G/A filed May 14, 2026 says.
Directors and officers
15
report now, of 15 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Athos Kg
SCHEDULE 13G/A · filed May 14, 2026 · Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Prof. Ugur Sahin, M.D.
SCHEDULE 13G/A · filed May 13, 2025 · Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
Ugur Sahin
SCHEDULE 13G/A · filed May 15, 2026 · Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
What BNTX reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
CGU Immunotherapies
An entity · structured entity · owns, named in the 20-F/A filed Jul 30, 2026
External Business of InstaDeep
An entity · structured entity · owns, named in the 20-F/A filed Jul 30, 2026
External Product Sales to JPT
An entity · structured entity · owns, named in the 20-F/A filed Jul 30, 2026
53 subsidiaries in 19 countries, from the list filed with the 20-F filed Mar 10, 2026.
Insider tradesForm 4
27sales
0purchases
27sales on a scheduled plan
2people selling
$89.8Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 9, 2025 to Oct 9, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Oct 9, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Sahin Ugur | Chief Executive Officer | 26 | $84.2M | 26 | 0 | $0 |
| Poetting Sierk | Chief Operating Officer | 1 | $5.5M | 1 | 0 | $0 |